Related Experiment Video
Updated: May 19, 2026

Solid Lipid Nanoparticles (SLNs) for Intracellular Targeting Applications
Published on: November 17, 2015
Engineering Bioactive Liposomal Nanoparticles for Kidney-Targeted ECFC Backpacks.
Brenda Cruz-Gonzalez1, Fei Fan1, Eva Hall1
1Department of Aerospace and Mechanical Engineering, Bioengineering Graduate Program, University of Notre Dame, Notre Dame, Indiana 46556, United States.
Engineered endothelial cells (ECFCs) with targeted nanoparticles show improved kidney cell binding for enhanced vascular repair and regeneration. This nanotechnology advances precision medicine for organ-specific therapies.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Nanotechnology
Background:
- Endothelial colony-forming cells (ECFCs) are crucial for vascular repair and kidney regeneration.
- Current limitations include poor selective homing and retention of ECFCs in target tissues.
Purpose of the Study:
- To enhance ECFC targeting to human renal proximal tubular epithelial cells.
- To develop a cell surface engineering strategy using kidney-targeted liposomal nanoparticles.
Main Methods:
- Conjugation of kidney-targeted liposomal nanoparticles to ECFCs via thiol-maleimide chemistry.
- Incorporation of a targeting peptide for receptor-mediated binding.
- Optimization of nanoparticle conjugation and loading while assessing ECFC phenotype and viability.
Main Results:
- Achieved enhanced binding of engineered ECFCs to renal epithelial cells in vitro.
- Demonstrated preservation of ECFC phenotypes and cellular function post-engineering.
- Showcased tunable nanoparticle properties for renal targeting and minimal off-target interactions with fibroblasts.
Conclusions:
- Surface-engineered ECFCs exhibit in vitro kidney cell selectivity.
- This approach provides a foundation for precision nanotechnology in regenerative therapies.
- The modular design offers potential for enhanced biocompatibility and organ-specific treatments.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Bioavailability Enhancement: Drug Permeability Enhancement

